0001209191-17-036145.txt : 20170530
0001209191-17-036145.hdr.sgml : 20170529
20170530164445
ACCESSION NUMBER: 0001209191-17-036145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170530
DATE AS OF CHANGE: 20170530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESTES DANIEL
CENTRAL INDEX KEY: 0001702527
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 17877985
MAIL ADDRESS:
STREET 1: C/O FRAZIER HEALTHCARE PARTNERS
STREET 2: 601 UNION ST., SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-25
0
0001290149
Sierra Oncology, Inc.
SRRA
0001702527
ESTES DANIEL
C/O FRAZIER HEALTHCARE PARTNERS
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
1
0
0
0
Stock Option (Right to Buy)
1.20
2017-05-25
4
A
0
50000
0.00
A
2027-05-25
Common Stock
50000
50000
D
Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on April 10, 2017.
The option vests as to 8.333% of the total shares monthly, beginning on June 25, 2017, with 100% of the total shares vested and exercisable on May 25, 2018, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Sukhi Jagpal as attorney-in-fact for Daniel Estes
2017-05-30